Related Topics News -

     
 Title only   |   Print 
     
《大行》花旗看好中國醫療板塊 首選藥明康德藥明生物

2025-07-11T  
《大行》匯豐研究:創新藥臨床試驗需求正轉向中國 上調泰格醫藥目標價至41.8元

2025-06-20T  
泰格醫藥H股末期息支付日期改為7月11日

2025-06-19T  
《大行》大和升泰格醫藥目標價至38元 續籲「持有」

2025-06-13T  
《大行》美銀上調再鼎醫藥目標價至29.61元 升泰格醫藥目標價至40.1元

2025-06-11T  
《大行》里昂:生物科技股大致完成首階段估值修復 料流動性及基本面可改善

2025-06-10T  
《大行》匯豐研究降泰格醫藥目標價至39.5元 新增訂單超預期

2025-05-15T  
《業績》泰格醫藥首季純利1.65億元人民幣 按年跌29.6%

2025-04-28T  
《大行》里昂:美關稅政策對中國醫療保健行業影響相對較小

2025-04-09T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.